Promoter hypomethylation regulates CD133 expression in human gliomas (Q46446472)

22 December 2017

title

Promoter hypomethylation regulates CD133 expression in human gliomas (English)

1 reference

22 December 2017

author name string

Kouichi Tabu

1 reference

22 December 2017

Ken Sasai

1 reference

22 December 2017

Taichi Kimura

1 reference

22 December 2017

Lei Wang

1 reference

22 December 2017

Eiko Aoyanagi

1 reference

22 December 2017

Shinji Kohsaka

1 reference

22 December 2017

Mishie Tanino

1 reference

22 December 2017

Hiroshi Nishihara

1 reference

22 December 2017

Shinya Tanaka

1 reference

22 December 2017

publication date

1 October 2008

1 reference

22 December 2017

published in

Cell Research

1 reference

22 December 2017

volume

1 reference

22 December 2017

issue

1 reference

22 December 2017

page(s)

1037-1046

1 reference

22 December 2017

The WHO classification of tumors of the nervous system

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Malignant glioma: genetics and biology of a grave matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

CD133+ neural stem cells in the ependyma of mammalian postnatal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Prominin: a story of cholesterol, plasma membrane protrusions and human pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Elucidation of Lyme arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

DNA methylation and gene silencing in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

DNA methylation in cancer: too much, but also too little

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

AC133-2, a novel isoform of human AC133 stem cell antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Stem cell marker CD133 affects clinical outcome in glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Nomenclature of prominin-1 (CD133) splice variants - an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Neural stem cell self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Induction of Tumors in Mice by Genomic Hypomethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

DNA hypomethylation leads to elevated mutation rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

Binding of intimin with Tir on the bacterial surface is prerequisite for the barrier disruption induced by enteropathogenic Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

A novel function of OLIG2 to suppress human glial tumor cell growth via p27Kip1 transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

7 January 2021

Cancer Stem Cells and Radiotherapy: New Insights Into Tumor Radioresistance

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

7 January 2021

Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

7 January 2021

Chromosomal Instability and Tumors Promoted by DNA Hypomethylation

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

7 January 2021

Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

7 January 2021

Reduced expression of the Aalpha subunit of protein phosphatase 2A in human gliomas in the absence of mutations in the Aalpha and Abeta subunit genes

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.270

7 January 2021

Identifiers

DOI

10.1038/CR.2008.270

1 reference

22 December 2017

1 reference

22 December 2017